FundedIQ
Biotechnology

iMicrobes: Funding, Investors & Team (Oct 2026)

iMicrobes is a synthetic biology company on a mission to accelerate the transition to sustainable materials. We have developed a bio-manufacturing process that turns greenhouse gases (GHG) like methane into a wide range of net-zero chemicals, based on our patented microorganisms. We are a team of techno-optimists, backed by Y Combinator and are committed to fueling the circular economy through innovation and industrial partnerships. If you are a chemical company interested in reducing your carbon emissions, let’s talk! www.imicrobes.com

imicrobes.com LinkedIn Alameda, United States 11-50 employees
Total raised
$10.0M
Rounds
1
Latest
Seed
Nov 2024

iMicrobes has raised $10.0M across 1 funding round on record, the most recent a Seed of $10.0M announced in Nov 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

iMicrobes Company Profile and Key Stats

Total funding raised
$10.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$10.0M in Nov 2024
Employees
11-50
reported band
Headquarters
Alameda, United States

Latest funding round on record: Nov 2024.

iMicrobes Funding Rounds

Date
Round
Amount
Seed
$10.0M

iMicrobes Founders and Leadership Team

Name
Role
Contact
Noah Helman
Founder
Locked

Contact details for the iMicrobes team: 1 of 1 has an email address on file.

Start 14-day free trial →

iMicrobes Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

iMicrobes' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like iMicrobes in Biotechnology and Alameda

Companies Similar to iMicrobes

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

iMicrobes Funding FAQs

What does iMicrobes do?

iMicrobes is a synthetic biology company on a mission to accelerate the transition to sustainable materials. We have developed a bio-manufacturing process that turns greenhouse gases (GHG) like methane into a wide range of net-zero chemicals, based on our patented microorganisms. We are a team of techno-optimists, backed by Y Combinator and are committed to fueling the circular economy through innovation and industrial partnerships. If you are a chemical company interested in reducing your carbon emissions, let’s talk! www.imicrobes.com

How much funding has iMicrobes raised?

iMicrobes has raised $10.0M across 1 round on record. The most recent is a Seed of $10.0M announced in Nov 2024.

When did iMicrobes last raise funding?

iMicrobes' most recent funding round on record is a Seed of $10.0M, announced in Nov 2024.

Who founded iMicrobes?

FundedIQ lists Noah Helman (Founder) at iMicrobes.

Where is iMicrobes headquartered?

iMicrobes is based in Alameda, California, United States.

How many employees does iMicrobes have?

iMicrobes is in the 11-50 employee band.

How does iMicrobes' funding compare to other Biotechnology startups?

iMicrobes' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's iMicrobes Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iMicrobes is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.